FDA Submits Information Collection for Review by Office of Management and Budget

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, which includes applications for FDA approval to market a new drug and postmarketing reports on authorized generic drugs.